We are excited to announce a new official distributor: Bayber, who will commercialize our robotic exoskeleton in Portugal. This partnership marks another important milestone in our mission to democratize access to robotic rehabilitation across Europe.
Bayber is a company specializing in the commercialization of advanced rehabilitation technology to hospitals, clinics, and centers in Portugal and Spain. They have a highly experienced technical and clinical team, with extensive expertise in neurorehabilitation as well as in marketing, sales, training, and servicing.
“We’re thrilled to join forces with a partner who shares our vision and values. Together, we’re committed to supporting clinical professionals every step of the way, from installation and hands-on training to technical support and, most importantly, achieving meaningful clinical outcomes for patients.” Alfons Carnicero, CEO at ABLE Human Motion.
Following this partnership, Bayber will begin marketing our exoskeleton with exclusivity in Portugal. With their experience and strong local presence, clinics in Portugal will now have easier access to the ABLE Exoskeleton, a device designed to make gait training more intuitive, versatile and efficient.
Bayber in Barcelona
In July 2025, we had the pleasure of welcoming Javier Ferrer, Founder and General Manager of Bayber, and Pablo Medrano, Clinical Applications Manager, to the headquarters of ABLE Human Motion in Barcelona. During the visit, the Bayber team had the chance to experience the exoskeleton firsthand and explore all its features. They also joined live sessions with end-users, witnessing the real impact of our technology in rehabilitation. The agenda included discussions on the key factors for a successful market launch and clinical integration, as well as a preview of prototypes for upcoming products currently in development.

“This partnership with ABLE Human Motion allows us to integrate state-of-the-art exoskeletons into Bayber, offering new opportunities for patient rehabilitation and care.” Javier Ferrer, Founder and General Manager at Bayber.
The ABLE Exoskeleton has already been adopted by leading neurorehabilitation centers in several European countries, helping people with spinal cord injury, multiple sclerosis, and neuromuscular diseases take their first steps in therapy. Now, Portuguese clinics will be able to integrate this cutting-edge technology into their rehabilitation programs, empowering both therapists and patients.
This launch reinforces our commitment to growing internationally and working hand-in-hand with trusted partners like Bayber to make robotic rehabilitation available for more people, in more places.
👉 Stay tuned for upcoming events and demonstrations in Portugal as we continue expanding access to the ABLE Exoskeleton.
If you are a clinic in Portugal, contact them for more information!